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Abstract
Background: Current criterion of waist circumference (WC) for abdominal obesity is not enough to demonstrate
characteristics of obese and non-obese populations defined by BMI. The aim of this study was to redefine the
cutoff values of WC according to general obesity (BMI ≥ 25 kg/m2).
Methods: The receiver operating characteristic curve analysis was performed to determine cutoff values of WC for
predicting atherosclerosis according to BMI in 1,063 non-diabetic subjects. To validate this new criterion, diabetic
patients (n = 3,690) were divided into three groups based on the current (WC of 90/80 cm for men/women) and
new cutoff values of WC: 1) group with WC below the lowest value of two criteria; 2) intermediate group defined
as having a WC between them; and 3) group with WC more than the highest value of them.
Results: The new cutoff values of WC for predicting atherosclerosis in non-diabetic subjects were 84/76 cm for
non-obese men/women, and 93/87 cm for obese men/women, respectively. Of non-obese diabetic patients, the
intermediate group (WC 84 ~ 90/76 ~ 80 cm for men/women) was more insulin resistant and showed elevated
odds ratio (OR) for having 2 or more metabolic risk factors compared to group with WC below 84/76 cm for men/
women [OR 2.48 (95 % CI 1.89–3.25) in men, 2.01 (95% CI 1.45–2.78) in women]. In contrast, among obese diabetic
patients, insulin resistance and the likelihood of having 2 or more metabolic risk factors were not different from the
intermediate group (WC 90 ~ 93/80 ~ 87 cm for men/women) and group with WC below 90/80 cm for men/
women.
Conclusions: The current universal cutoff values of WC may under- or over-estimate the metabolic risks of intermediate
groups. Therefore, the WC criteria for abdominal obesity should be applied differently depending on the BMI.
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Background
Obesity is known as a potent risk factor for metabolic dis-
order and cardiovascular disease [1]. The relationship
between obesity and cardiovascular disease depends not
only on the amount of body fat but also on its distribution
[2, 3]. Recently, increasing evidence has shown that ab-
dominal obesity is critical risk factor for the development
of insulin resistance, metabolic syndrome, type 2 diabetes,
and cardiovascular disease [4–7]. Abdominal obesity is
defined according to ethnically specific values of waist
circumference (WC). The cutoff value for abdominal
obesity in the Korean population was defined as ≥ 90 cm
for men and ≥ 80 cm for women according to Asian-
Pacific guideline [8].
However, without consideration for general obesity, it is
not appropriate that we use same WC cutoff value for
abdominal obesity. For instance, individuals who have been
described as “metabolically healthy obese”, the obese
phenotype may exist in the absence of metabolic abnormal-
ities such as dyslipidemia, insulin resistance, hypertension
and an unfavorable inflammatory profile [9–11]. Similarly
not all non-obese individuals present with a healthy meta-
bolic profile [12]. Such discrepancies between obesity and
metabolic abnormalities have been explained by several fac-
tors, including fat distribution [13]. It is necessary to separ-
ately define the precise criteria for abdominal obesity by
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WC according to the presence or absence of general obes-
ity. However, to the best of our knowledge, no previous
studies have attempted to redefine the cutoff value of WC
for abdominal obesity in each obese and non-obese individ-
ual. The aim of this study was to redefine the cutoff value
of WC for abdominal obesity according to general obesity.
Methods
Subjects
In the present study, 1,063 non-diabetic subjects were
enrolled who had undergone a medical check-up at the
Korea Association of Health Promotion Center in Seoul,
Korea. In addition, 3,690 consecutive patients with type
2 diabetes who visited diabetes clinic at the Huh’s Dia-
betes Center, Seoul, Korea were also enrolled. All partici-
pants were aged 18 years or above and individuals with
acute disease, known liver or kidney disease, or a history of
cancer were excluded. Anthropometric assessments were
performed, blood pressure was measured, and laboratory
tests and carotid ultrasonography were performed in all
study participants. To evaluate insulin resistance in
diabetic patients, a short insulin tolerance test (SITT) was
performed and assessed by the rate constant for plasma
glucose disappearance (Kitt). Medical histories were
collected through personal interview. All participants
signed consent forms and the Institutional Review
Board of Severance Hospital at Yonsei University College
of Medicine approved this study.
Clinical and laboratory measurements
Height and weight were measured in all subjects while
wearing light clothing and no shoes. WC was measured
at the midpoint between the inferior border of the sub-
costal margin and iliac crest in the mid-axillary line after
normal expiration with the subject standing. Blood pres-
sure was measured using a mercury sphygmomanometer
in a sitting position after the participants had remained
seated for 10 min. Venous blood samples were obtained
after an overnight fast of at least 8 h and fasting plasma
glucose, total cholesterol, triglyceride, and high-density
lipoprotein (HDL)-cholesterol were measured. Hemoglobin
A1c (HbA1c) was analyzed using high performance liquid
chromatography (Variant II, Bio-Rad, CA, U.S.A.) in
subjects with type 2 diabetes.
Assessment of mean carotid artery intima-media
thickness (C-IMT)
The common carotid arteries were scanned bilaterally
using a high-resolution real-time B-mode ultrasonog-
raphy (Toshiba SSA-270A, Japan in non-diabetic sub-
jects; LOGIQ 7, GE, Milwaukee, WI, USA, in diabetic
subjects) with a 10-MHz linear transducer. Scanning
was performed at the mid- and distal-common carotid
artery by a lateral longitudinal projection. The C-IMT
was measured at three points on the far wall of the mid-
and distal-common carotid artery, 1 cm proximal to the
dilatation of the carotid bulb, and the mean value of six
measurements from the right and left common carotid
arteries were used. C-IMT was defined as the distance
between the lumen-intima interface and the media-
adventitia interface. A plaque was defined as a localized
protrusion into the vessel lumen with thickening of the
vessel wall of > 50 % compared to the adjacent C-IMT.
Measurement of insulin resistance
The SITT was carried out at 8.00 a.m., after an overnight
fast. With the subject at rest, 0.1 U per kg of body
weight of a 100 times diluted short-acting human insulin
(Humulin-R, Eli Lilly, IN, U.S.A.) was administered via
the vein, and a blood sample was obtained from the op-
posite vein at 0, 3, 6, 9, 12, and 15 min. Plasma glucose
concentrations were determined immediately after sam-
pling using a Beckman glucose analyzer II (Beckman
Ins., Fullertone, CA, USA), and then Kitt was calculated
from the slope of the fall in log transformed plasma glu-
cose between 3 and 15 min. Immediately after the test,
100 mL of 20 % dextrose solution was administered
intravenously to avoid potential hypoglycemia.
Definitions of general obesity, atherosclerosis, and
metabolic risk factors
General obesity was defined as a BMI ≥ 25 kg/m2. Ath-
erosclerosis was defined as history of coronary artery
disease or cerebrovascular disease or presence of plaque
or thickened C-IMT greater than 1 SD compared with
age & sex matched mean value in non-diabetic subjects
[14] (Additional file 1: Table S1). We used the criteria for
metabolic risk factors proposed by the modified National
Cholesterol Education Program Adult Treatment Panel III
definition: high serum triglyceride levels (≥150 mg/dL),
high blood pressure (systolic, ≥ 130 mmHg; diastolic, ≥
85 mmHg; or the use of antihypertensive medications),
low serum HDL-cholesterol levels (<40 mg/dL for men, <
50 mg/dL for women) [15].
Statistical analysis
The receiver operating characteristic (ROC) curve ana-
lysis was performed to determine cutoff values of WC
yielding the maximum sensitivity and specificity for pre-
dicting atherosclerosis in non-diabetic subjects. The new
cutoff was chosen by maximizing the sums of the
Youden’s index where (sensitivity + specificity)—1.
To validate these new criteria, diabetic patients were
divided into three groups based on the current (WC of
90/80 cm for men/women) and new cutoff values of WC
according to gender and general obesity: 1) group with
WC below the lowest value of two criteria; 2) intermedi-
ate group defined as having a WC between them; and 3)
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group with WC more than the highest value of them.
Data for continuous variables are presented as the mean ±
SD and categorical factors are reported as percentages.
Comparisons between the groups were tested using the
chi-Square test or one-way ANOVA followed by Tukey’s b
post-hot test, as appropriate. Odds ratios (OR) for having 2
or more metabolic risk factors in each group were deter-
mined using logistic regression analysis, and the group
having WC below the lowest value of current and new
criteria was used as the reference. ANCOVA was used to
adjust for age, diabetes duration, current smoking, and
medication usage in multivariate analysis. A p value < 0.05
was considered significant. All statistical analyses were
performed using IBM SPSS Statistics (version 19.0; IBM
Co., Somers, NY, USA).
Results
Table 1 shows the clinical and biochemical characteris-
tics of the non-diabetic subjects. The mean age was
51.1 years and the mean BMI was 24.5 kg/m2. Approxi-
mately 21 % of the men and 25 % of the women were
found to have atherosclerosis.
The optimal WC measurements as obtained from
ROC curves were used for predicting atherosclerosis in
non-diabetic subjects were 84 cm in non-obese men,
76 cm in non-obese women, 93 cm in obese men, and
87 cm in obese women, respectively. These new cutoff
values displayed the maximal Youden’s index compared
with current cutoff values. Sensitivity, specificity, positive
and negative predictive values are also presented in
Table 2.
When applying the current and new cutoff values of
WC in diabetic patients, the intermediate group was
defined as having WC between 84 ~ 90 cm/76 ~ 80 cm
for non-obese (BMI < 25 kg/m2) men/women, or having
WC between 90 ~ 93 cm/80 ~ 87 cm for obese (BMI ≥
25 kg/m2) men/women. In non-obese diabetic patients,
the intermediate group had higher blood pressure,
higher triglyceride and lower HDL-cholesterol levels
than the group with WC of < 84/76 cm for men/women.
The intermediate group tended to have similar metabolic
profiles as the group with WC of ≥ 90/80 cm for men/
women. C-IMT was higher in the intermediate group of
non-obese diabetic women than that in the group with
WC of < 76 cm. Fasting glucose, HbA1c, and the fre-
quency of atherosclerosis did not different among each
group (Table 3). In contrast, among obese diabetic
patients, metabolic components such as fasting glucose,
blood pressure, and lipid profiles were similar in the
three groups, except systolic blood pressure in obese
men and HbA1c and triglyceride in obese women. C-
IMT and the frequency of atherosclerosis did not differ
significantly between the intermediate group and the
group with WC of < 90/80 cm (Table 3).
Significant differences were seen in insulin resistance
defined by Kitt between non-obese diabetic group with
WC of < 84/76 cm for men/women and the others, but
no difference was found between the intermediate group
Table 1 Clinical and biochemical characteristics of the non-diabetic subjects according to sex
Men Women Total
N 565 498 1063
Age (years) 49.9 ± 11.4 52.5 ± 9.9 51.1 ± 10.8
Height (cm) 168.8 ± 5.7 155.4 ± 5.1 162.5 ± 8.6
Weight (kg) 69.4 ± 9.1 59.6 ± 8.5 64.8 ± 10.1
Body mass index (kg/m2) 24.3 ± 2.8 24.7 ± 3.2 24.5 ± 3.0
History of coronary artery disease, n (%) 19 (3.4) 28 (5.6) 47 (4.4)
History of cerebrovascular disease, n (%) 14 (2.5) 14 (2.8) 28 (2.6)
Waist circumference (cm) 86.2 ± 7.5 82.1 ± 8.5 84.3 ± 8.2
Systolic blood pressure (mm Hg) 129.9 ± 17.5 131.0 ± 20.0 130.4 ± 18.7
Diastolic blood pressure (mm Hg) 80.4 ± 11.9 79.9 ± 12.7 80.2 ± 12.3
Fasting glucose (mg/dL) 96.6 ± 14.9 93.3 ± 14.7 95.0 ± 14.9
Total cholesterol (mg/dL) 199.0 ± 33.1 206.1 ± 37.2 202.3 ± 35.2
Triglyceride (mg/dL) 188.8 ± 134.8 148.4 ± 146.2 169.8 ± 141.6
HDL-cholesterol (mg/dL) 44.0 ± 9.8 51.2 ± 13.7 47.3 ± 12.3
C-IMT (mm) 0.68 ± 0.17 0.68 ± 0.16 0.68 ± 0.16
Carotid plaque, n (%) 28 (5.0) 26 (5.2) 54 (5.1)
Atherosclerosis, n (%) 120 (21.2) 126 (25.3) 246 (23.1)
Data are expressed as the mean ± standard deviation or number
HDL high-density lipoprotein; C-IMT mean carotid artery intima-media thickness
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and the group with WC of ≥ 90/80 cm for men/women
(Fig. 1a and b). In obese diabetic patients, the intermedi-
ate group had higher Kitt values than the group with
WC of ≥ 93/87 cm for men/women. Kitt did not differ
between the intermediate group and the group with WC
of < 80 cm for women (Fig. 1c and d).
The ORs for having 2 or more metabolic risk factors
according to WC categorized by new and current cutoff
values in diabetic patients are shown in Table 4. Of non-
obese diabetic patients, the intermediate group were
2.48 times (95 % CI 1.89–3.25) in men and 2.01 times
(1.45–2.78) in women, more likely to have 2 or more
metabolic risk factors compared to the group with WC
below 84/76 cm for men/women, after adjusting for age,
diabetes duration, smoking status, and medication usage.
In contrast, in obese diabetic patients, ORs were not sig-
nificantly different between the intermediate group and
the group with WC below 90/80 cm for men/women.
Discussion
It has been well known that abdominal obesity and vis-
ceral fat, in particular, play an important role in various
cardiovascular and metabolic diseases [4–7]. Because BMI
does not distinguish the distribution of fat, WC, which is
mainly correlated with the distribution of visceral adipose
tissue, has been recommended for the specific assessment
of abdominal obesity [16–18]. However, current criterion
of WC for abdominal obesity is not enough to demon-
strate characteristics of obese and non-obese populations
defined by BMI. In the present study, we had separately
redefined the cutoff value of WC in obese and non-obese
population. Our findings may suggest that the current cut-
off value of WC underestimated metabolic risks in some
non-obese people and overestimated that in some obese
people.
In the Asian-Pacific region, the cutoff value for abdom-
inal obesity is defined as ≥ 90 cm for men and ≥ 80 cm for
women [8]. The WC cutoffs have been based on available
data linking WC with cardiovascular disease and other
metabolic syndrome components in different populations
[19]. The Korean Society for the Study of Obesity
suggested Korean-specific WC cut points of 90 cm for
men and 85 cm for women [20]. In addition, WC cutoff
values for identifying the presence of insulin resistance
and visceral obesity were proposed as 87 cm for men and
81 cm for women in Koreans with type 2 diabetes [21].
However, because abdominal obesity as defined by WC is
not enough to capture or explain the metabolic risks for
the whole population, other factors such as age and BMI
should also be considered. In Japanese-American subjects,
a study reported age and gender-specific cut points for ab-
dominal obesity with the International Diabetes Feder-
ation criteria. For men, the optimal cut points for WC
were 90.0 cm (age < 57 years) and 87.1 cm (age ≥ 57 years).
For women, the optimal cut points for WC were 80.8 cm
(age < 56 years) and 89.0 cm (age ≥ 56 years) [22]. These
results indicated that WC cutoff values were different ac-
cording to age. Another study on abdominal obesity found
different sets of WC values associated with increased risk
for cardiovascular disease at the designated BMI values:
90 cm for men and 83 cm for women at 25 kg/m2 BMI
and 100 cm for men and 93 cm for women at 30 kg/m2
BMI [23]. But, to the best of our knowledge, no previous
studies have explored WC cutoff values according to
general obesity.
Accumulating evidence suggests that not all obese sub-
jects are at increased cardiometabolic risk and not all non-
obese are at lower risk. The term, metabolically healthy
obesity, has been used to describe an obese phenotype that
does not have the burden of any metabolic disorder [9–13].
Conversely, metabolically unhealthy non-obese subjects
have been defined as normal BMI and having various
metabolic risk factors [12, 13]. Insulin resistance, blood
pressure, fasting glucose, lipid profiles, and inflamma-
tory markers are included to define metabolic health
but there is no standard definition to discriminate
metabolically healthy individuals from those that are
metabolically unhealthy [10, 24–26]. In the present
study, metabolic profiles such as triglyceride and HDL-
cholesterol concentrations and Kitt in the intermediate
group (WC of 84 ~ 90 cm in men and 76 ~ 80 cm in
women) are similar to those in the group with WC of ≥
Table 2 Comparison of waist circumference cutoff values for abdominal obesity to predict atherosclerosis in non-diabetic subjects
Cutoff (cm) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Youden’s index
Non-obese (BMI < 25 kg/m2) Men 84 57.6 66.9 26.8 88.3 24.5
90 16.9 95.0 41.7 84.5 11.9
Women 76 75.4 47.2 28.7 87.2 22.6
80 46.2 68.0 28.8 81.8 14.2
Obese (BMI ≥ 25 kg/m2) Men 90 68.9 37.8 29.2 76.5 6.7
93 44.3 67.7 33.8 76.6 12.0
Women 80 98.4 8.5 31.7 92.3 6.9
87 70.5 53.2 39.4 80.6 23.7
PPV positive predictive value; NPV negative predictive value
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Table 3 Clinical characteristics of diabetic patients according to sex, waist circumference (WC) and BMI
Men Non-obese (BMI < 25 kg/m2) Obese (BMI ≥ 25 kg/m2)
WC < 84 cm WC 84~90 cm (intermediate) WC ≥ 90 cm WC < 90 cm WC 90~93 cm (intermediate) WC ≥ 93 cm
N 839 347 56 398 166 309
Age (years) 55.2 ± 10.8 57.5 ± 10.1 60.5 ± 9.1*, ** 52.9 ± 10.0 53.6 ± 11.1 55.1 ± 12.7
Body mass index (kg/m2) 22.1 ± 1.8 23.8 ± 0.9* 24.2 ± 0.7* 26.2 ± 1.0 27.0 ± 1.2* 28.8 ± 2.6*, **
Waist circumference (cm) 78.5 ± 4.6 86.9 ± 1.7* 92.7 ± 2.0*, ** 87.1 ± 2.5 92.0 ± 0.8* 98.5 ± 5.0*, **
Systolic blood pressure (mm Hg) 128.5 ± 17.6 133.3 ± 16.9* 139.4 ± 17.7*, ** 134.3 ± 16.6 135.0 ± 15.1 138.1 ± 15.3*, **
Diastolic blood pressure (mm Hg) 83.1 ± 11.0 86.4 ± 10.9* 89.7 ± 11.9*, ** 88.6 ± 11.2 89.0 ± 10.2 89.9 ± 11.6
Fasting glucose (mg/dL) 163.2 ± 67.3 158.7 ± 53.2 145.8 ± 47.0 151.8 ± 49.9 149.2 ± 47.7 152.5 ± 53.3
HbA1C (%) 8.5 ± 2.3 8.3 ± 1.8 7.9 ± 1.1 8.0 ± 1.7 7.9 ± 1.4 8.2 ± 1.9
HbA1C (mmol/mol) 69 ± 25 67 ± 20 63 ± 12 64 ± 19 63 ± 15 66 ± 21
Total cholesterol (mg/dL) 186.5 ± 39.7 189.2 ± 34.8 193.5 ± 44.7 185.9 ± 37.9 185.8 ± 35.8 190.2 ± 36.5
Triglyceride (mg/dL) 117.8 ± 71.8 153.8 ± 83.2* 164.2 ± 92.5* 154.7 ± 84.6 151.9 ± 69.4 162.3 ± 71.1
HDL-cholesterol (mg/dL) 51.8 ± 14.1 46.4 ± 12.1* 45.4 ± 13.2* 45.5 ± 10.7 46.0 ± 10.5 44.8 ± 10.8
C-IMT (mm) 0.85 ± 0.19 0.88 ± 0.20 0.91 ± 0.20* 0.84 ± 0.18 0.86 ± 0.19 0.89 ± 0.19*
Diabetes duration (year) 8.8 ± 8.1 8.6 ± 7.7 8.4 ± 7.2 6.8 ± 6.4 6.8 ± 7.0 6.5 ± 7.2
Atherosclerosis (%) 362 (43.1) 156 (45.0) 25 (44.6) 175 (44.0) 81 (48.8) 156 (50.5)
Anti-hypertensive medication (%) 179 (21.3) 94 (27.1) 22 (39.3)*** 110 (27.6) 61 (36.7) 120 (38.8)***
Statin (%) 59 (7.0) 36 (10.4) 6 (10.7) 41 (10.3) 23 (13.9) 45 (14.6)
Women Non-obese (BMI < 25 kg/m2) Obese (BMI ≥ 25 kg/m2)
WC < 76 cm WC 76~80 cm (intermediate) WC ≥ 80 cm WC < 80 cm WC 80~87 cm (intermediate) WC ≥ 87 cm
N 506 242 218 69 267 273
Age (years) 57.0 ± 9.5 59.3 ± 9.5* 60.2 ± 7.8* 57.9 ± 10.8 58.9 ± 9.5 59.8 ± 9.0
Body mass index (kg/m2) 21.3 ± 1.9 23.1 ± 1.1* 23.8 ± 0.9*, ** 26.1 ± 1.1 27.0 ± 1.3* 29.2 ± 2.8*, **
Waist circumference (cm) 71.4 ± 4.3 78.4 ± 1.1* 83.9 ± 2.6*, ** 78.6 ± 1.7 84.4 ± 1.9* 92.7 ± 4.6*, **
Systolic blood pressure (mm Hg) 131.6 ± 19.3 137.0 ± 17.1* 138.6 ± 19.9* 138.7 ± 15.6 139.3 ± 17.8 142.8 ± 18.9
Diastolic blood pressure (mm Hg) 81.7 ± 11.4 84.3 ± 10.0* 84.8 ± 11.3* 85.5 ± 9.3 85.1 ± 10.8 87.9 ± 11.9
Fasting glucose (mg/dL) 154.6 ± 64.0 157.1 ± 58.7 153.5 ± 53.7 143.1 ± 52.8 147.3 ± 51.1 153.0 ± 54.0
HbA1C (%) 8.1 ± 2.1 8.3 ± 1.7 8.4 ± 1.7 7.8 ± 1.8 8.0 ± 1.7 8.3 ± 1.6
*
HbA1C (mmol/mol) 66 ± 23 67 ± 19 68 ± 19 62 ± 20 64 ± 19 67 ± 18
*
Total cholesterol (mg/dL) 192.4 ± 39.4 200.4 ± 41.4* 202.4 ± 37.1* 197.0 ± 34.5 202.4 ± 39.4 203.4 ± 38.5
Triglyceride (mg/dL) 111.0 ± 63.4 146.7 ± 79.3* 153.0 ± 78.4* 129.2 ± 54.5 147.3 ± 73.6 161.4 ± 73.3*
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Table 3 Clinical characteristics of diabetic patients according to sex, waist circumference (WC) and BMI (Continued)
HDL-cholesterol (mg/dL) 58.0 ± 14.7 52.7 ± 13.0* 51.8 ± 12.8* 50.3 ± 11.9 51.7 ± 11.5 48.9 ± 12.7
C-IMT (mm) 0.80 ± 0.18 0.83 ± 0.16* 0.85 ± 0.17* 0.82 ± 0.17 0.85 ± 0.19 0.86 ± 0.17
Diabetes duration (year) 8.5 ± 7.2 8.8 ± 7.1 9.4 ± 7.2 6.3 ± 6.6 7.3 ± 6.8 7.8 ± 6.9
Atherosclerosis (%) 214 (42.3) 116 (47.9) 107 (49.1) 34 (49.3) 132 (49.4) 144 (52.7)
Anti-hypertensive medication (%) 130 (25.7) 94 (38.8) 79 (36.2)*** 23 (33.3) 100 (37.5) 126 (46.2)***
Statin (%) 67 (13.2) 40 (16.5) 36 (16.5) 9 (13.0) 35 (13.1) 42 (15.4)
Data are expressed as the mean ± standard deviation or number
HDL high-density lipoprotein; C-IMT mean carotid artery intima-media thickness
*P<0.05 vs. Group with WC of < 84/76 cm for non-obese men/women or group with WC of < 90/80 cm for obese men/women
**P<0.05 vs. Intermediate group
***P<0.05
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90/80 cm for men/women among non-obese diabetic
patients. This intermediate group may represent the
characteristics of the metabolically unhealthy non-
obese population [13, 27]. On the other hand, in the
obese diabetic patients, the intermediate group (WC of
90 ~ 93 cm in men and 80 ~ 87 cm in women) had
similar metabolic profiles to the group with WC of
< 90/80 cm for men/women. This finding is compatible
with previously published data on metabolically healthy
obese participants [12, 28]. Therefore, in order to
Fig. 1 Differences in a Kitt (%/min) according to current and new cutoff values of waist circumference (WC) in diabetic patients. a in non-obese men;
b in non-obese women; c in obese men; d in obese women. In non-obese patients, intermediate group represent lower Kitt value compared to group
with WC of < 84/76 cm in men/women. In obese patients, intermediate group represent higher Kitt value than group with WC of ≥ 93/87 cm in
men/women. *, p < 0.05
Table 4 Odds ratios for predicting 2 or more metabolic risk factors in diabetic patients
Men Non-obese (BMI < 25 kg/m2) Obese (BMI ≥ 25 kg/m2)
WC < 84 cm WC 84~90 cm (intermediate) WC ≥ 90 cm WC < 90 cm WC 90~93 cm (intermediate) WC ≥ 93 cm
Unadjusted OR 1 2.52 (1.94-3.29) 4.65 (2.67-8.10) 1 1.00 (0.70-1.44) 1.44 (1.07-1.94)
Adjusted ORa 1 2.48 (1.89-3.25) 4.39 (2.48-7.75) 1 0.96 (0.66-1.39) 1.47 (1.08-2.00)
Women Non-obese (BMI < 25 kg/m2) Obese (BMI ≥ 25 kg/m2)
WC < 76 cm WC 76~80 cm (intermediate) WC ≥ 80 cm WC < 80 cm WC 80~87 cm (intermediate) WC ≥ 87 cm
Unadjusted OR 1 2.29 (1.67-3.14) 2.91 (2.09-4.03) 1 0.90 (0.53-1.53) 1.72 (1.00-2.94)
Adjusted ORa 1 2.01 (1.45-2.78) 2.51 (1.78-3.54) 1 0.91 (0.53-1.57) 1.75 (1.00-3.05)
aAdjusted for age, diabetes duration, smoking status, medication usage (insulin, oral anti-diabetic drugs, anti-hypertensive medication, statin)
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distinguish these groups more accurately, it is necessary
to redefine WC cutoff values for abdominal obesity
based on their general obesity (as defined from BMI).
Similar to the intermediate group in non-obese diabetic
patients, metabolically unhealthy non-obese subjects were
more commonly found in the Asian population than in
Western population [29]. The studies have shown that
Asians have a higher level of visceral fat within the same
BMI values compared to Caucasians, so the increased risk
for metabolic syndrome and cardiovascular disease is
present [30, 31]. In a Finnish type 2 diabetes survey, meta-
bolically unhealthy non-obese individuals had higher 2-h
postload glucose levels (p = 0.003), higher non-alcoholic
fatty liver disease scores (p < 0.001), and higher cardiovas-
cular disease risk scores (Framingham, p < 0.001; SCORE,
p = 0.002) than metabolically healthy obese individuals
[32]. Therefore, it might be necessary to lower WC cutoff
values in individuals with normal BMI in order to appro-
priately manage individuals categorized into intermediate
group.
Although there was no universally accepted definition of
metabolically healthy obese, many studies have found that
individuals with the metabolically healthy obese pheno-
type are not at increased risk for diabetes, cardiovascular
disease, and all-cause mortality [11, 12, 33]. Conversely,
metabolically healthy obesity was found to be associated
with cardiovascular and all-cause mortality in some stud-
ies [25, 34, 35]. Until now, many clinicians have the per-
ception that metabolically healthy obesity is an early stage
of the metabolic risk groups. The intermediate group in
obese diabetic patients might have been categorized by
metabolically healthy obese in aforementioned studies.
Therefore close attention should be paid to these patients
and redefinition of the WC cutoff values to higher mea-
surements than the current cutoff values to help de-
monstrate absolutely higher metabolic risk in the obese
population should be considered.
One of the strengths in the present study was that we
used atherosclerosis instead of metabolic syndrome com-
ponents to define WC cutoff value for abdominal obesity.
Although many studies has used metabolic syndrome
components (except WC criteria) to define WC cutoff
value, we chose atherosclerosis defined by C-IMT or his-
tory of coronary artery disease or cerebrovascular disease
because it is a more accurate and precise marker for car-
diovascular diseases. In addition, when we verified new
WC cutoff values in diabetic patients, we compared insu-
lin resistance calculated by SITT among three groups.
SITT is a more accurate method for the evaluation of in
vivo insulin sensitivity compared to the homeostasis
model assessment of insulin resistance in humans. On the
other hand, because this cross-sectional study included
only the Korean population, the results cannot be applied
directly to other ethnic populations. Our results might be
different in other ethnic populations because the Korean
population is not obese than Western population. Ultra-
sonography is highly operator-dependent. In the present
study, however, two other sonographers performed the ca-
rotid doppler separately in the non-diabetic and the dia-
betic population, and the intra-observer variability was
not checked. The present study investigated differences in
insulin resistance and the likelihood of having poor meta-
bolic profiles among groups, but not differences in specific
atherosclerotic markers. Moreover, cardiovascular event
and all-cause mortality was not fully assessed. Future pro-
spective studies on the risk of suggested WC cutoff values
and the incidence of cardiovascular morbidity and mortal-
ity are needed.
Conclusions
In conclusion, the criteria for abdominal obesity defined by
current cutoff values of WC may underestimate the meta-
bolic risks in some non-obese people and overestimate that
in some obese people. The optimal cutoff of WC may be
84/76 cm in non-obese men/women and 93/87 cm in obese
men/women, respectively. The application of these new
cutoff values of WC according to BMI may be useful to
identify the subjects with poor metabolic profile dispropor-
tionate to their underlying BMI and to prevent misclassifi-
cation some metabolically healthy obese subjects were
mistakenly classified as being at high risk. Therefore, we
propose that the criteria of WC for abdominal obesity
should be applied differently depending on the BMI.
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